|
91
|
264
|
3jzbA |
Crystal structure of tr-alfa bound to the selective thyromimetic triac |
|
92
|
251
|
3k22A |
Glucocorticoid receptor with bound alaninamide 10 with tif2 peptide |
|
80
|
239
|
3k6pA |
Estrogen related receptor alpha in complex with an ether based ligand |
|
85
|
259
|
3jzcA |
Crystal structure of tr-beta bound to the selective thyromimetic triac |
|
87
|
252
|
3k23A |
Glucocorticoid receptor with bound d-prolinamide 11 |
|
90
|
241
|
3ipqA |
X-ray structure of gw3965 synthetic agonist bound to the lxr-alpha |
|
87
|
242
|
3ipuA |
X-ray structure of benzisoxazole urea synthetic agonist bound to the lxr-alpha |
|
90
|
256
|
3ixpA |
Crystal structure of the ecdysone receptor bound to byi08346 |
|
92
|
261
|
3imyA |
Structure of tr-beta bound to selective thyromimetic gc-1 |
|
81
|
242
|
3ipsA |
X-ray structure of benzisoxazole synthetic agonist bound to the lxr-alpha |
|
94
|
267
|
3ilzA |
Structure of tr-alfa bound to selective thyromimetic gc-1 in p212121 space group |
|
87
|
243
|
3ixpD |
Crystal structure of the ecdysone receptor bound to byi08346 |
|
92
|
268
|
3ia6A |
X-ray crystal structure of the nuclear hormone receptor ppar-gamma in a complex with a ppar gamma/alpha dual agonist |
|
113
|
317
|
3hvlA |
Tethered pxr-lbd/src-1p complexed with sr-12813 |
|
89
|
251
|
3hq5A |
Progesterone receptor bound to an alkylpyrrolidine ligand. |
|
95
|
270
|
3hodA |
Crystal structure of the ppargamma-lbd complexed with a new aryloxy-3phenylpropanoic acid |
|
93
|
270
|
3ho0A |
Crystal structure of the ppargamma-lbd complexed with a new aryloxy-3phenylpropanoic acid |
|
92
|
263
|
3hzfA |
Structure of tr-alfa bound to selective thyromimetic gc-1 in c2 space group |
|
79
|
245
|
3hlvA |
Crystal structure of human estrogen receptor alpha ligand-binding domain in complex with a glucocorticoid receptor interacting protein 1 nr box ii peptide and 16-alpha-hydroxy-estrone ((8s,9r,13s,14r,16r)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6h-cyclopenta[a]phenanthren-17-one |
|
85
|
251
|
3h52A |
Crystal structure of the antagonist form of human glucocorticoid receptor |
|
86
|
229
|
3hc5A |
Fxr with src1 and gsk826 |
|
84
|
243
|
3hm1A |
Crystal structure of human estrogen receptor alpha ligand-binding domain in complex with a glucocorticoid receptor interacting protein 1 nr box ii peptide and estrone ((8r,9s,13s,14s)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-one) |
|
98
|
272
|
3h0aD |
Crystal structure of peroxisome proliferator-activated receptor gamma (pparg) and retinoic acid receptor alpha (rxra) in complex with 9-cis retinoic acid, co-activator peptide, and a partial agonist |
|
76
|
230
|
3hc6A |
Fxr with src1 and gsk088 |
|
83
|
229
|
3gd2A |
Isoxazole ligand bound to farnesoid x receptor (fxr) |
|
97
|
270
|
3gwxA |
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors |
|
77
|
242
|
3gyuA |
Nuclear receptor daf-12 from parasitic nematode strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 7 |
|
94
|
242
|
3gytA |
Nuclear receptor daf-12 from parasitic nematode strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 4 |
|
106
|
269
|
3gz9A |
Crystal structure of peroxisome proliferator-activated receptor delta (ppard) in complex with a full agonist |
|
61
|
228
|
3h0aA |
Crystal structure of peroxisome proliferator-activated receptor gamma (pparg) and retinoic acid receptor alpha (rxra) in complex with 9-cis retinoic acid, co-activator peptide, and a partial agonist |
|
102
|
249
|
3gn8A |
X-ray crystal structure of ancgr2 in complex with dexamethasone |
|
90
|
259
|
3gwsX |
Crystal structure of t3-bound thyroid hormone receptor |
|
94
|
229
|
3fxvA |
Identification of an n-oxide pyridine gw4064 analogue as a potent fxr agonist |
|
100
|
267
|
3g8iA |
Aleglitazar, a new, potent, and balanced ppar alpha/gamma agonist for the treatment of type ii diabetes |
|
84
|
230
|
3fugA |
Crystal structure of the retinoid x receptor ligand binding domain bound to the synthetic agonist 3-[4-hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic acid |
|
104
|
271
|
3g9eA |
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type ii diabetes |
|
95
|
251
|
3g8oA |
Progesterone receptor with bound pyrrolidine 1 |
|
97
|
249
|
3g0wA |
Crystal structure of the rat androgen receptor ligand binding domain complex with an n-aryl-oxazolidin 2-imine inhibitor |
|
80
|
230
|
3fs1A |
Crystal structure of hnf4a lbd in complex with the ligand and the coactivator pgc-1a fragment |
|
100
|
271
|
3gbkA |
Crystal structure of human ppar-gamma ligand binding domain complexed with a potent and selective agonist |
|
99
|
272
|
3furA |
Crystal structure of pparg in complex with int131 |
|
93
|
241
|
3fc6B |
Hrxralpha & mlxralpha with an indole pharmacophore, sb786875 |
|
97
|
271
|
3fejA |
Design and biological evaluation of novel, balanced dual ppara/g agonists |
|
76
|
233
|
3fc6A |
Hrxralpha & mlxralpha with an indole pharmacophore, sb786875 |
|
99
|
267
|
3feiA |
Design and biological evaluation of novel, balanced dual ppara/g agonists |
|
88
|
228
|
3fliA |
Discovery of xl335, a highly potent, selective and orally-active agonist of the farnesoid x receptor (fxr) |
|
70
|
231
|
3falA |
Humanrxr alpha & mouse lxr alpha complexed with retenoic acid and gsk2186 |
|
90
|
240
|
3f7dA |
Sf-1 lbd bound by phosphatidylcholine |
|
87
|
242
|
3falB |
Humanrxr alpha & mouse lxr alpha complexed with retenoic acid and gsk2186 |
|
80
|
243
|
3f5cA |
Structure of dax-1:lrh-1 complex |
